Search hospitals > Texas > Amarillo
The Don and Sybil Harrington Cancer Center
Claim this profileAmarillo, Texas 79106
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
91 reported clinical trials
4 medical researchers
Summary
The Don and Sybil Harrington Cancer Center is a medical facility located in Amarillo, Texas. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. The Don and Sybil Harrington Cancer Center is involved with conducting 91 clinical trials across 197 conditions. There are 4 research doctors associated with this hospital, such as Anita Ravipati, Brian T. Pruitt, Daniel Arsenault, and Jeffery D. Hanrahan.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage I
Stage III
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Anita RavipatiThe Don and Sybil Harrington Cancer Center1 year of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
30 reported clinical trials
56 drugs studied
Brian T. PruittThe Don and Sybil Harrington Cancer Center6 years of reported clinical research
Studies Breast Cancer
Studies Thyroid Cancer
2 reported clinical trials
4 drugs studied
Daniel ArsenaultThe Don and Sybil Harrington Cancer Center11 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
2 reported clinical trials
6 drugs studied
Jeffery D. HanrahanThe Don and Sybil Harrington Cancer Center8 years of reported clinical research
Studies Germ Cell Tumors
Studies Uterine Tumors
1 reported clinical trial
5 drugs studied
Clinical Trials running at The Don and Sybil Harrington Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Breast cancer
Testicular cancer
Ovarian Tumors
Ovarian Choriocarcinoma
Ovarian Carcinoma
Rectal Cancer
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The Don and Sybil Harrington Cancer Center?
The Don and Sybil Harrington Cancer Center is a medical facility located in Amarillo, Texas. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. The Don and Sybil Harrington Cancer Center is involved with conducting 91 clinical trials across 197 conditions. There are 4 research doctors associated with this hospital, such as Anita Ravipati, Brian T. Pruitt, Daniel Arsenault, and Jeffery D. Hanrahan.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.